A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Dengue viruses (DENV) infect 50 to 100 million people worldwide per year, of which 500,000 develop severe life-threatening disease. This mosquito-borne illness is endemic in most tropical and subtropical countries and has spread significantly over the last decade. While there are several promising v...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Byrd, Chelsea M., Dai, Dongcheng, Grosenbach, Douglas W., Berhanu, Aklile, Jones, Kevin F., Cardwell, Kara B., Schneider, Christine, Wineinger, Kristin A., Page, Jessica M., Harver, Chris, Stavale, Eric, Tyavanagimatt, Shanthakumar, Stone, Melialani A., Bartenschlager, Ralf, Scaturro, Pietro, Hruby, Dennis E., Jordan, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535982/
https://ncbi.nlm.nih.gov/pubmed/23070172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01429-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados